Evaluation of a murine model of hepatic candidiasis
- PMID: 2394804
- PMCID: PMC268055
- DOI: 10.1128/jcm.28.8.1828-1841.1990
Evaluation of a murine model of hepatic candidiasis
Abstract
A murine model of focal hepatic candidiasis which we suggest simulates certain conditions of this clinical variant of systemic candidiasis in leukemic patients is described. We have shown that outbred mice inoculated with Candida albicans by the oral-intragastric route as infants (6 days old) and then immunocompromised by cyclophosphamide and cortisone acetate treatment 2 weeks later demonstrate systemic spread of the opportunistic pathogen to the liver, lungs, spleen, and kidneys. Treatment with the immunosuppressive drugs cyclophosphamide and cortisone acetate resulted in alteration of the normal integrity of the mucosal epithelium of the gut as well as in granulocytopenia. Approximately 55% of the animals with C. albicans infections in the liver demonstrated hepatic abscesses. After these same infected, immunocompromised animals were treated with suboptimal dosages of antifungal agents (cilofungin or amphotericin B), either by intraperitoneal or subcutaneous (s.c.) routes, persistent hepatic abscesses were fewer in number and delimited by a distinct outer layer of host tissue but still contained large numbers of the viable pathogen. Blood cell counts indicated that these antifungal drug-treated animals had reestablished approximately the same number of leukocytes per microliter of blood as estimated prior to the immunocompromising drug treatment. Similar conditions in leukemic patients who were in remission and who were undergoing antifungal drug therapy for systemic candidiasis have been reported. Clearance of hepatic infections in mice was accomplished by using appropriate concentrations of amphotericin B administered by daily intraperitoneal or s.c. injection for 5 to 7 days or cilofungin by continuous s.c. infusion for 7 days. However, systemic antifungal therapy did not significantly reduce numbers of C. albicans cells in the stomach and esophagus. Persistent foci of gastrointestinal colonization by C. albicans, especially in the region of the cardial-atrium fold of the stomach of these mice, are reservoirs of the opportunistic pathogen from which reinfection may occur, leading to relapse of systemic candidiasis.
Similar articles
-
Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.Antimicrob Agents Chemother. 1993 Apr;37(4):729-36. doi: 10.1128/AAC.37.4.729. Antimicrob Agents Chemother. 1993. PMID: 8494367 Free PMC article.
-
Gastrointestinal and systemic candidosis in immunocompromised mice.J Med Vet Mycol. 1989;27(6):363-80. doi: 10.1080/02681218980000491. J Med Vet Mycol. 1989. PMID: 2628558
-
Synergy between cilofungin and amphotericin B in a murine model of candidiasis.Antimicrob Agents Chemother. 1991 Jul;35(7):1334-7. doi: 10.1128/AAC.35.7.1334. Antimicrob Agents Chemother. 1991. PMID: 1929290 Free PMC article.
-
Candida and candidaemia. Susceptibility and epidemiology.Dan Med J. 2013 Nov;60(11):B4698. Dan Med J. 2013. PMID: 24192246 Review.
-
Invasive candidiasis during granulocytopenia.Recent Results Cancer Res. 1993;132:137-45. doi: 10.1007/978-3-642-84899-5_14. Recent Results Cancer Res. 1993. PMID: 8265854 Review.
Cited by
-
Homologs of the yeast neck filament associated genes: isolation and sequence analysis of Candida albicans CDC3 and CDC10.Mol Gen Genet. 1994 Mar;242(6):689-98. doi: 10.1007/BF00283424. Mol Gen Genet. 1994. PMID: 8152419
-
Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.Infect Immun. 1996 Nov;64(11):4514-9. doi: 10.1128/iai.64.11.4514-4519.1996. Infect Immun. 1996. PMID: 8890200 Free PMC article.
-
Effects of cyclophosphamide and ceftriaxone on gastrointestinal colonization of mice by Candida albicans.Antimicrob Agents Chemother. 1996 Sep;40(9):2221-3. doi: 10.1128/AAC.40.9.2221. Antimicrob Agents Chemother. 1996. PMID: 8878613 Free PMC article.
-
Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.Eur J Epidemiol. 1992 May;8(3):477-83. doi: 10.1007/BF00158585. Eur J Epidemiol. 1992. PMID: 1397212 No abstract available.
-
Antifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasis.Antimicrob Agents Chemother. 1991 Jul;35(7):1321-8. doi: 10.1128/AAC.35.7.1321. Antimicrob Agents Chemother. 1991. PMID: 1929288 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical